Your browser doesn't support javascript.
loading
Glucocorticoid-induced cardiomyopathy: unexpected conclusion.
Sheikh, Taha; Shuja, Hina; Zaidi, Syeda Ramsha; Haque, Ayema.
Afiliação
  • Sheikh T; Department of Internal Medicine, University of Toledo, Toledo, Ohio, USA taha.sheikh@utoledo.edu.
  • Shuja H; Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan.
  • Zaidi SR; Department of Internal Medicine, St Joseph Mercy Health System, Livonia, Michigan, USA.
  • Haque A; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
BMJ Case Rep ; 13(11)2020 Nov 09.
Article em En | MEDLINE | ID: mdl-33168535
ABSTRACT
Glucocorticoid excess is an under-recognised cause of cardiovascular adverse effects. The sources can be either endogenous (Cushing's syndrome) or exogenous (Anabolic steroid abuse). Cardiovascular complications due to excess glucocorticoid includes hypertension, left ventricular hypertrophy, myocardial infarction, and heart failure. Although anabolic steroid-induced cardiomyopathy is a well-recognised phenomenon, endogenous corticosteroid-induced cardiomyopathy and heart failure are rarely reported sequelae of glucocorticoid excess in the body. We report a glucocorticoid-induced dilated cardiomyopathy in a 26-year-old African-American man with cushingoid features and symptomatic heart failure.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Cushing / Glucocorticoides / Cardiomiopatias Tipo de estudo: Diagnostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Cushing / Glucocorticoides / Cardiomiopatias Tipo de estudo: Diagnostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article